Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.

Study findings

The 12-month follow-up associated Cerebrolysin with greater functional independence. Mortality was 18% in both groups.

Population and setting

Selected thrombectomy patients; propensity-matched historical controls

Evidence type

Human comparative study

Preparation

See the original report; formulation details require verification.

Source language

eng

Title source

Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

Study limitations

• Historical controls and residual confounding limit causal interpretation.
• An extension of a previously reported cohort is not an independent trial; linkage to earlier thrombectomy reports requires reconciliation.
• Full methods and risk of bias have not been independently assessed.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed record and available abstract checked; full text not reviewed.

Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.1007/s12975-026-01414-z

Citation and original source

Original source: Staszewski J, Dębiec A, Gniadek-Olejniczak K, Stępień A, Piusinska-Macoch R, Strilciuc S, Balo D, Harston G, Brzozowski K, Zięcina P, Narloch J, Wierzbicki M, Piasecki P. Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort. Translational stroke research; 2026 Feb 2026.

Molekul research summary: https://molekul.io/research/cbl-update-41739286. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Related compound profiles